Related Experiment Video
Updated: Jun 23, 2026

Studying Proteolysis of Cyclin B at the Single Cell Level in Whole Cell Populations
Published on: September 17, 2012
A splice variant of cyclin D2 regulates cardiomyocyte cell cycle through a novel protein aggregation pathway
Qian Sun1, Feixiong Zhang, Karim Wafa
1Department of Pharmacology, Sir Charles Tupper Medical Building, Dalhousie University, Halifax, NS, B3H 1X5 Canada.
Abstract:
The mammalian heart lacks intrinsic ability to replace diseased myocardium with newly divided myocytes. There is scant information on mechanisms regulating cell cycle exit in cardiomyocytes. We cloned a splice variant of cyclin D2 (D2SV) from the mouse heart and found a novel role for this protein in cardiomyocyte cell cycle exit. We report that D2SV is highly expressed in embryonic myocardium compared with the adult heart. Localization studies indicate that D2SV is retained in the endoplasmic reticulum (ER), Golgi and lysosomal compartments and subjected to ER-stress-associated protein aggregation. D2SV aggregation relies on the motor activities of dynein and is blocked by ER stress modulators. The ability of D2SV to sequester other cell cycle proteins provides a mechanistic explanation for its effects on cardiomyocyte cell cycle. We show that D2SV-induced cell cycle exit can be rescued by overexpression of D-type and B-type cyclins. We suggest that protein aggregation may be a major block for cardiomyocyte cell cycle reactivation.
Insights
A novel protein variant, cyclin D2 splice variant (D2SV), identified in mouse hearts, halts cardiomyocyte cell division. This discovery offers insights into preventing heart muscle regeneration by understanding cell cycle exit mechanisms.
Area of Science:
- Cardiovascular Biology
- Cell Cycle Regulation
- Molecular Cardiology
Background:
- Mammalian hearts have limited capacity for myocyte regeneration.
- Mechanisms controlling cardiomyocyte cell cycle exit are poorly understood.
Purpose of the Study:
- To investigate the role of a novel cyclin D2 splice variant (D2SV) in cardiomyocyte cell cycle exit.
- To elucidate the molecular mechanisms underlying D2SV function in heart development and regeneration.
Main Methods:
- Cloning and characterization of mouse D2SV.
- Immunofluorescence and subcellular localization studies.
- Analysis of protein-protein interactions and aggregation.
- Manipulation of D2SV expression and cell cycle activity in cardiomyocytes.
Main Results:
- D2SV is highly expressed in embryonic myocardium and decreases in adult hearts.
- D2SV localizes to the endoplasmic reticulum, Golgi, and lysosomes, undergoing ER-stress-associated aggregation.
- D2SV aggregation is dependent on dynein motor activity and modulated by ER stress.
- D2SV sequesters other cell cycle proteins, promoting cell cycle exit.
- Overexpression of D-type and B-type cyclins can rescue D2SV-induced cell cycle arrest.
Conclusions:
- D2SV plays a critical role in cardiomyocyte cell cycle exit during development.
- Protein aggregation of D2SV may represent a significant barrier to cardiomyocyte cell cycle reactivation and heart repair.
Related Concept Videos
Positive Regulator Molecules
Positive Regulator Molecules
Anaphase Promoting Complex
RNA Splicing
Inhibition of Cdk Activity
Separation of Sister Chromatids
At the onset of anaphase, separase, a proteolytic enzyme, is...
